Correspondence 0001193125-23-050745 from Peak Bio, Inc. (PKBO, PKBOW) (CIK 0001834645)
Peak Bio, Inc. (PKBO, PKBOW) (CIK 0001834645)
Date: Feb. 27, 2023 · CIK: 0001834645 · Accession: 0001193125-23-050745
AI Filing Summary & Sentiment
File numbers found in text: 333-268801
Letter
VIA EDGAR United States Securities and Exchange Commission Division of Corporation Finance Office of Life Sciences Attention: James McNamara Re: Peak Bio, Inc. Acceleration Request for Registration Statement on Form S-1 File No. 333-268801
Dear Mr. McNamara,
Pursuant to Rule 461 under the Securities Act of 1933, as amended (the “Act”), Peak Bio, Inc. (the “Company”) hereby requests that the effective date of the above-referenced registration statement (the “Registration Statement”) be accelerated to March 1, 2023, at 4:01 p.m., Eastern Time, or as soon thereafter as practicable, unless we or our outside counsel, DLA Piper LLP (US), request by telephone that such Registration Statement be declared effective at some other time. In making this acceleration request, the Company acknowledges that it is aware of its responsibilities under the Act.
Once the Registration Statement is effective, please orally confirm the event with our counsel, DLA Piper LLP (US) by calling Scott A. Cowan at (973) 520-2554.
If you have any questions regarding this request, please contact Scott A. Cowan of DLA Piper LLP (US) at (973) 520-2554.
Sincerely,
PEAK BIO, INC.
Show Raw Text
CORRESP 1 filename1.htm CORRESP VIA EDGAR February 27, 2023 United States Securities and Exchange Commission Division of Corporation Finance Office of Life Sciences 100 F Street, N.E. Washington, D.C. 20549 Attention: James McNamara Re: Peak Bio, Inc. Acceleration Request for Registration Statement on Form S-1 File No. 333-268801 Dear Mr. McNamara, Pursuant to Rule 461 under the Securities Act of 1933, as amended (the “Act”), Peak Bio, Inc. (the “Company”) hereby requests that the effective date of the above-referenced registration statement (the “Registration Statement”) be accelerated to March 1, 2023, at 4:01 p.m., Eastern Time, or as soon thereafter as practicable, unless we or our outside counsel, DLA Piper LLP (US), request by telephone that such Registration Statement be declared effective at some other time. In making this acceleration request, the Company acknowledges that it is aware of its responsibilities under the Act. Once the Registration Statement is effective, please orally confirm the event with our counsel, DLA Piper LLP (US) by calling Scott A. Cowan at (973) 520-2554. If you have any questions regarding this request, please contact Scott A. Cowan of DLA Piper LLP (US) at (973) 520-2554. Sincerely, PEAK BIO, INC. /s/ Stephen LaMond Stephen LaMond Interim Chief Executive Officer cc: Andrew P. Gilbert, DLA Piper LLP (US) Scott A. Cowan, DLA Piper LLP (US)